Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Trial for Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic Radiosurgery

Phase 1

Active, not recruiting

Conditions: Metastatic Spine Lesions

Interventions: Radiation: single-fraction radiation
Device: MRI and/or CT

First Posted Date: 2014-10-30

Last Posted Date: 2024-11-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 9

Registration Number: NCT02278744

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Pilot Study to Assess the Amnesic Properties of Propofol in Pediatric Patients

Not Applicable

Completed

Conditions: Pediatric Pateints
Amnesic Properties of Propofol

Interventions: Other: memory test
Drug: Propofol

First Posted Date: 2014-10-29

Last Posted Date: 2018-01-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 69

Registration Number: NCT02278003

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer

Phase 2

Completed

Conditions: Metastatic Prostate Cancer
Pain

Interventions: Drug: Radium-223

First Posted Date: 2014-10-29

Last Posted Date: 2023-04-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 29

Registration Number: NCT02278055

Locations: 🇺🇸
New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity

Completed

Conditions: Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients

Interventions: Device: cardiac MRI with DWI

First Posted Date: 2014-10-24

Last Posted Date: 2020-09-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 28

Registration Number: NCT02274480

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States

Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers

Phase 1

Completed

Conditions: Ovarian Cancer
Endometrial Cancer

Interventions: Drug: Paclitaxel
Drug: Carboplatin
Drug: Selinexor

First Posted Date: 2014-10-21

Last Posted Date: 2021-04-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 23

Registration Number: NCT02269293

Locations: 🇺🇸
Memoral Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States

Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

Phase 2

Active, not recruiting

Conditions: Allogeneic Hematopoietic Stem Cell

Interventions: Other: No fecal microbiota transplantation (FMT), routine management
Biological: fecal microbiota transplantation (FMT)

First Posted Date: 2014-10-20

Last Posted Date: 2024-07-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 59

Registration Number: NCT02269150

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Phase 1

Completed

Conditions: Advanced Gastrointestinal Stromal Tumor (GIST)

Interventions: Drug: BGJ398
Drug: Imatinib Mesylate

First Posted Date: 2014-10-06

Last Posted Date: 2020-03-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 16

Registration Number: NCT02257541

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

and more 4 locations

Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy

Phase 2

Active, not recruiting

Conditions: Metastatic HER2-Positive Breast Cancer

Interventions: Drug: Gemcitabine
Drug: Trastuzumab
Drug: Pertuzumab

First Posted Date: 2014-09-30

Last Posted Date: 2024-11-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 45

Registration Number: NCT02252887

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Hartford Healthcare Cancer Institute @ Hartford Hospital, Hartford, Connecticut, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 2 locations

Care For The Cancer Caregiver: A Meaning-Based Workshop To Help Manage Caregiver Burden

Not Applicable

Completed

Conditions: Caregivers

Interventions: Other: webcasts
Behavioral: Assessments
Other: Usual care

First Posted Date: 2014-09-26

Last Posted Date: 2018-08-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 88

Registration Number: NCT02250911

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal Irradiation

Completed

Conditions: Childhood Cancer Survivors Treated With Abdominal Radiation

First Posted Date: 2014-09-25

Last Posted Date: 2019-10-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 42

Registration Number: NCT02248779

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy